Valuation: Almirall, S.A.

Market Cap 2.33B 2.66B 2.15B 1.98B 3.73B 256B 3.81B 25.65B 10.09B 126B 10B 9.78B 432B P/E 2026 *
26.9x
P/E 2027 * 19.2x
Enterprise Value 2.21B 2.53B 2.04B 1.88B 3.54B 243B 3.62B 24.36B 9.58B 119B 9.49B 9.28B 410B EV / Sales 2026 *
1.8x
EV / Sales 2027 * 1.52x
Free-Float
35.93%
Yield 2026 *
1.83%
Yield 2027 * 2.01%
1 day+0.38%
1 week-4.98%
Current month-5.15%
1 month-4.13%
3 months-16.43%
6 months-19.21%
Current year-16.82%
1 week 10.52
Extreme 10.52
11.26
1 month 10.52
Extreme 10.52
11.8
Current year 10.52
Extreme 10.52
13.98
1 year 10.06
Extreme 10.06
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
15.35
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 2022-11-01
Director of Finance/CFO 53 2025-08-30
Chief Tech/Sci/R&D Officer - 2021-07-06
Director TitleAgeSince
Director/Board Member - 2013-12-31
Director/Board Member - 2015-12-31
Chairman - 2022-05-05
Date Insider Type Main position Quantity % Market Cap.
6/23/23 Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 Buy 4,340 0.0024%
6/22/23 Buy

Executive/Senior Manager

6,000 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%-4.98%-0.19%+32.42% 2.66B
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average -0.02%-0.01%+25.66%+51.76% 357.77B
Weighted average by Cap. +0.37%+0.02%+37.48%+79.59%

Financials

2026 *2027 *
Net sales 1.23B 1.41B 1.13B 1.05B 1.97B 136B 2.02B 13.56B 5.33B 66.37B 5.28B 5.17B 228B 1.36B 1.56B 1.25B 1.16B 2.18B 150B 2.23B 15B 5.9B 73.38B 5.84B 5.71B 253B
Net income 85.57M 97.92M 78.96M 72.79M 137M 9.43B 140M 944M 371M 4.62B 368M 360M 15.9B 119M 136M 110M 101M 191M 13.12B 195M 1.31B 516M 6.42B 512M 500M 22.12B
Net Debt -117M -134M -108M -99.76M -188M -12.92B -192M -1.29B -509M -6.33B -504M -493M -21.79B -256M -293M -236M -218M -411M -28.22B -420M -2.82B -1.11B -13.82B -1.1B -1.08B -47.58B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,108
Date Price Change Volume
26-07-17 €10.68 +0.38% 235,492
26-07-16 €10.64 -0.19% 114,417
26-07-15 €10.66 -0.74% 108,425
26-07-14 €10.74 -1.29% 123,160
26-07-13 €10.88 -3.20% 127,713
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.68EUR
Average target price
14.45EUR
Spread / Average Target
+35.30%

Quarterly revenue - Rate of surprise